Peculiarities of the course of ulcerative colitis in children at the present stage
Keywords:ulcerative colitis, peculiarities of the course, children
AbstractBackground. As to severity of the course, the incidence of complications and mortality rate, ulcerative colitis hold a position within the top of the gastrointestinal system diseases in children. Goal of research — to study peculiarities of the course of ulcerative colitis at the present stage. Materials and methods. The retrospective analysis was conducted of 184 clinical records of the children, who were on examination and treatment at the Department of the diseases of gastrointestinal system of the State Institution “Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine” between 2004 and 2014. Results and discussion. Ulcerative colitis is common in the children of all ages, among which the preschool children and teenagers are at greater risk than others. The risk factors include both the antenatal and the postnatal ones: gestational toxicosis and miscarriage threat, weight deficit at birth, artificial feeding, intestinal infections. Ulcerative colitis is characterized by chronic relapse, slow progression of the disease, and the typical clinical symptoms are: diarrhea, hemorrhagic colitis, abdominal pain syndrome, toxic syndrome, late physical development. In terms of localization, the inflammation process most often affects the entire large bowel (59.6 %), left-sided colitis (28.5 %), and proctosigmoiditis (accounts for 11.9 %) are less common. The informative criteria of ulcerative colitis activity are the Pediatric Ulcerative Colitis Activity Index (PUCAI), fecal calprotectin level, a number of complete blood count values (hemoglobin, leucocytes, platelets, erythrocyte sedimentation rate) and biochemical studies (C-reactive protein, alpha-2 globulins). The modern combined baseline therapy is efficient in 22 % of patients suffering from total colitis, in 42–58 % — from left-sided colitis according to the follow-up study results. Monotherapy with 5-aminosalicylic acid medications was efficient in 68 % of patients with the least active segmental colitis and in 100 % of patients with proctosigmoiditis. Conclusion. Analysis of the clinical records of the children with ulcerative colitis has showed the current age pattern of the disease, the gender difference depending on localization and severity of the inflammation and destructive processes in the bowel, incongruity of the clinical and the laboratory findings, efficiency of the treatment patterns suggested by ECCO and ESPGAN, relevance of the use of new criteria to assess the inflammation process in the bowel. The findings received can be used for substantiation of the research and practice program on the problem of ulcerative colitis in the children aimed at the development of the relevant branches, such as epidemiology, pathogenesis, age clinical features, optimization of clinical practice guidelines.
Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines. JPGN. 2012;55(3):340-61. PMID: 22773060; doi: 10.1097/MPG.0b013e3182662233.
IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis — the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41(1):1-7. PMID: 15990620.
Sandhu BK, Fell JM, Beattie RM, Mitton SG, Wilson DC, Jenkins H, compilers. Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom. J Pediatr Gastroenterol Nut. 2010;50(1):S1-13. doi: 10.1097/MPG.0b013e3181c92c53.
Shadrin OG, compiler. Crohn’s disease in children: state of the problem and the prospects of its solution in Ukraine. Zdorov’ja Ukrainy. Medychna gazeta. 2015;1:3-4. (in Ukrainian).
Mack DR, Langton C, Markowitz J, Leleiko N, Griffiths A, Bousvaros A, et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. 2007;119(6):1113-9. PMID: 17545378; doi: 10.1542/peds.2006-1865.
Behrens R, Buderus W, Keller K. Crohn's disease and ulcerative colitis in children and adolescents: a practical guide. Freiburg: Dr Falk Pharma Gmbh; 2005. 46p.
Rumyantsev VG, Schigoleva NE. Ulcerative colitis in children. Consilium medicum; Appendix. Gastroenterology. 2002;2:20. (in Russian).
Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133(2):423-32. PMID: 17681163. doi: 10.1053/j.gastro.2007.05.029.
Turner D, Travis SP, Griffiths AM, et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011;106(4):574-88. PMID: 21224839. doi: 10.1038/ajg.2010.481.
Copyright (c) 1970 M.F. Denisova, N.M. Muzyka, N.V. Cherneha, T.D. Zadorozhna, T.M. Archakova, N.Yu. Bukulova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.